EMUU:LSE:LSE-iShares VII PLC - iShares MSCI EMU USD Hedged ETF Acc (USD)

ETF | Others |

Last Closing

USD 11.958

Change

+0.01 (+0.05)%

Market Cap

N/A

Volume

68.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-2.60 (-1.25%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.02 (-0.08%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 640.06B
0R1I:LSE NVIDIA Corp.

-6.15 (-4.33%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.06 (-0.18%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

+0.90 (+1.27%)

USD 266.08B
0QZO:LSE 0QZO

+1.00 (+0.90%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.70 (-3.12%)

USD 202.26B
0R24:LSE Intel Corp.

-0.56 (-2.75%)

USD 196.14B

ETFs Containing EMUU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.79% 89% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.79% 89% A- 81% B-
Trailing 12 Months  
Capital Gain 14.44% 83% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.44% 81% B- 76% C+
Trailing 5 Years  
Capital Gain 109.02% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 109.02% 87% B+ 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 13.24% 72% C 75% C
Dividend Return 13.24% 71% C- 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.36% 52% F 70% C-
Risk Adjusted Return 99.13% 88% B+ 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike